Omnia Family Wealth’s Gilead Sciences GILD Stock Holding History

Omnia Family Wealth’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,663	Closed	-$204K	–	100
2025 Q4	$204K	Buy	+1,663	New	+$202K	0.06%	100
2025 Q3	–	Sell	-1,813	Closed	-$201K	–	106
2025 Q2	$201K	Buy	+1,813	New	+$193K	0.07%	98
2019 Q2	–	Sell	-14	Closed	-$1K	–	263
2019 Q1	$1K	Hold	14	–	–	﹤0.01%	534
2018 Q4	$1K	Sell	14 -57	-80%	-$3.98K	﹤0.01%	497
2018 Q3	$5K	Hold	71	–	–	﹤0.01%	309
2018 Q2	$5K	Sell	71 -283	-80%	-$20K	﹤0.01%	311
2018 Q1	$27K	Sell	354 -137	-28%	-$10.9K	0.01%	187
2017 Q4	$35K	Buy	491 +21	+4%	+$1.59K	0.02%	183
2017 Q3	$38K	Buy	470 +343	+270%	+$26.2K	0.02%	162
2017 Q2	$9K	Sell	127 -266	-68%	-$17.7K	﹤0.01%	299
2017 Q1	$27K	Buy	393 +215	+121%	+$15.1K	0.01%	192
2016 Q4	$13K	Buy	+178	New	+$13.2K	0.01%	257

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Omnia Family Wealth's GILD Position: Q1 2026 in Review

Omnia Family Wealth sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 1,663 shares — an estimated $204K sold.

Omnia Family Wealth first reported a position in GILD in Q4 2016 and held it in 12 quarters. The position peaked at $204K in Q4 2025. 2,329 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Omnia Family Wealth reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
Omnia Family Wealth sold 1,663 Gilead Sciences shares in Q1 2026, an estimated $204K.
Omnia Family Wealth first reported a position in Gilead Sciences in Q4 2016 and held it in 12 quarters.
Omnia Family Wealth's Gilead Sciences position peaked at $204K in Q4 2025.
2,329 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Omnia Family Wealth's 13F filing for Q1 2026, filed 7 May 2026.